The drug candidate, azenosertib, was being tested against solid tumors in an early-stage study and in patients with a type of ovarian and uterine cancer in two mid-stage studies.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/CURxDHn
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment